CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
5 research outputs found
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome
Author
Eliquis (apixaban) Package Insert
Nayer A
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
Diagnosis, prognosis and therapeutic management of acute pulmonary embolism
Author
Anderson FA
ELIQUIS® (apixaban) tablets for oral use
+12 more
Heit JA
Janssen Scientific Affairs LLC
Kearon C
Konstantinides SV
Portola Pharmaceuticals
PRADAXA® (dabigatran etexilate mesylate) capsules for oral use
Raskob GE
SAVAYSA® (edoxaban) tablets for oral use
Schellhaass A
White RH.
XARELTO® (rivaroxaban) tablets for oral use
Yusuf HR
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Assessing and Reversing the Effect of Direct Oral Anticoagulants on Coagulation
Author
Ansell
Arachchillage
+57 more
Ashikhmina
Boehringer Ingelheim Pharmaceuticals Inc.: Dabigatran Prescribing Information
Boehringer Ingelheim Pharmaceuticals Inc.: Idarucizumab Prescribing Information
Bristol-Myers Squibb: Apixaban Prescribing Information
Chai-Adisaksopha
Cini
Connolly
Cuker
Culbreth
Daiichi Sankyo Co.: Edoxaban Prescribing Information
Douketis
Eche
Flaherty
Francart
Gosselin
Grottke
Harder
Harenberg
Hawes
Henskens
Hillarp
Hillarp
Huisman
Königsbrügge
LabCorp: Apixaban anti-Xa test 504385
Levy
Levy
Levy
Lindahl
Majeed
Marino
Marlu
Narouze
Perzborn
Piran
Pollack
Pollack
Portola Pharmaceuticals Communication: Limitations of Commercial Anti-Factor Xa Activity Assays in the Presence of Andexanet Alfa. MP-AnXa-US-0160 March 2019
Portola Pharmaceuticals Inc.: Andexanet Alfa Prescribing Information
Portola Pharmaceuticals Inc.: Betrixaban Prescribing Information
Pragst
Reilly
Rottenstreich
Samuelson
Schulman
Seiffge
Seiffge
Simon
Song
Steffel
Steffel
Testa
Testa
Tomaselli
van Ryn
Witt
Zahir
Publication venue
'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study
No full text
Crossref
New orally active anticoagulants in critical care and anesthesia practice: The good, the bad and the ugly
Author
Agnelli
Alberts
+93 more
Alves
Anurag Bajaj
Apixaban
Arquizan
Augoustides
Banerjee
Barrios
Baumann
Becattini
Blanco-Molina
Bommer
Bozzato
Brand
Burness
Cabral
Cairns
Camm
Carter
Chang
Coccheri
Cohen
Cohen
De
Deedwania
Deedwania
Deeks
Deftereos
Deitelzweig
Deitelzweig
Dempfle
Dentali
Diener
Diener
Doggrell
Dumkow
Easton
Eikelboom
Frost
Giorgi
Haas
Hankey
Harenberg
Hart
Haschke
Hohnloser
Imberti
Jones
Kaatz
Kamel
Kubitza
Kubitza
Le
Le
Lee
Liew
Liew
Lip
Littrell
Lopes
Mahan
Mantha
Mantha
Merli
Michel
Miller
Morales-Vidal
Patel
Pisters
Raghavan
Rasmussen
Rosenberg
Ru
Ruiz-Giménez
Salmela
Schellong
Schneeweiss
Spannagl
Stangier
Stangier
Stroke
SukhminderJit Singh Bajwa
Suárez
Táborský
Ufer
van
van
Vishal Sehgal
Walenga
Weinz
Welle
Wooten
Wysokinski
Yasaka
Publication venue
'Medknow'
Publication date
01/01/2013
Field of study
No full text
Crossref
The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants
Author
Abraham
Adam
+113 more
Adams
Albertsen
Alexander
Amin
Ansell
Baglin
Bajpai
Bhardwaj
Brodsky
Camm
Camm
Capodanno
Chen
Clemens
Connolly
Crowther
Crowther
Crowther
Culebras
Dans
del Zoppo
Deore
Dewilde
Di Nisio
Diener
Douxfils
Dzeshka
Easton
Eikelboom
ELIQUIS (apixaban) tablets
Fox
Fuster
Fuster
Fuster
Gage
Gage
Gallagher
Gallus
Ghaswalla
Giugliano
Glund
Graham
Granger
Guo
Guo
Gurk-Turner
Gómez-Outes
Halperin
Halvorsen
Hankey
Hart
Heidbuchel
Heidbuchel
Heidbuchel
Hirsh
Holbrook
Hori
Hori
Hylek
January
Karthikeyan
Keogh
Kitchen
Kralev
Kubitza
Kubitza
Laliberté
Lamberts
Lane
Larsen
Larsen
Lauffenburger
Laulicht
Lee
Lin
Lip
Lip
Lip
Lip
Lip Lip
Lu
Mant
Mega
Molteni
Oldgren
Olesen
Omran
Patel
Perzborn
Pisters
Pollack
Porsche
Potpara
PRADAXA® (dabigatran etexilate mesylate)
Reynolds
ROCKET AF Study Investigators
Ruff
Sabir
Sardar
Scaglione
Schulman
Shen
Sorbera
Stangier
Stroke Risk in Atrial Fibrillation Working Group.
Stöllberger
The Stroke Prevention in Atrial Fibrillation Investigators
van Asch
van Ryn
Velu
Wolf
Wolf
Xian
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref